Please wait
Healthcare · Medical Instruments & Supplies · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$13.5B
15.0%
N/A
Current price
$26.08
-0.2% todayUpdated 3 min ago
Open
$25.99
Previous close
$26.13
Day range
$25.79 – $26.35
Volume
N/A
Limited data
Awaiting filing
15.0% yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for BAX, with its range and direction at a glance.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Investors usually follow BAX for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is mixed because income looks acceptable with a 15.0% yield while there is no strong bear warning from the current data. Whisone has moderate conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
$126M
TTM (2026-06-30)
ROE
-14.4%
Return on equity
ROA
2.8%
Return on assets
Debt / equity
1.56
Lower is usually safer.
P/B ratio
2.18
Useful for book value support.
Dividend yield
15.0%
Current income signal.
85/100
Direction
Range-bound
Main supports
Recent price behavior and momentum still support follow-through.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Fair value
$27.43
Analyst view
Hold
Analyst target
$28.73
Forecast refresh
Updated 10h ago
Quality score
64
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
$0.17
2025-02-28
Payment: TBA | Qualification: 2025-02-28 | Yield at declaration: N/A
$0.17
2024-11-29
Payment: TBA | Qualification: 2024-11-29 | Yield at declaration: N/A
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Sideways
-0.3% across the latest saved price window.
Volatility
Low
Beta is 0.59. Price has historically moved more calmly than the wider market.
52-week position
73% of range
Price is sitting around the middle of its 52-week range.
Volume confirmation
N/A
Comparable volume data is not available.
Price: $26.08
P/E: N/A
Yield: 15.0%
ABBV
AbbVie Inc.
Price: $256.22
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.02
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $158.16
P/E: 27.310226
Yield: 0.0%
Industry
Medical Instruments & Supplies
Employees
37500
Exchange
NYQ
Ticker
BAX
